Action LINCOLN LINCOLN PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Lincoln Pharmaceuticals Limited

Actions

LINCOLN

INE405C01035

Temps Différé Bombay S.E.
Autres places de cotation
 06:44:24 10/05/2024 		Varia. 5j. Varia. 1 janv.
556,2 INR +0,78% Graphique intraday de Lincoln Pharmaceuticals Limited -6,85% -8,69%
30/03 Lincoln Pharmaceuticals Limited annonce que Pirabhai Suthar cessera d'être un administrateur indépendant CI
22/02 Lincoln Pharmaceuticals Limited annonce la démission de Meha Patel en tant qu'administratrice indépendante non exécutive CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022
Lincoln Pharmaceuticals : Newspaper Advertisements
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action LINCOLN
  4. Actualités Lincoln Pharmaceuticals Limited
  5. Autres langues